Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8211294 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 30 Pages |
Abstract
Doses of â¥66 Gy might be associated with improved outcomes in high-performance patients undergoing definitive re-IMRT. Postoperatively, doses of 50 to 66 Gy appear adequate after removal of gross disease. Hyperfractionation and elective neck irradiation were not associated with an obvious benefit and might increase toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jimmy J. MD, PhD, Matthew C. MD, Nadeem MD, MS, Sara J. MD, Musaddiq J. MD, Neal E. MD, Derek MD, PhD, Comron BS, John A. MD, Dwight E. MD, MBA, FACRO, FACR, Samuel MD, Drexell H. MD, Chandana A. MS, Joshua MD, James A. MD, Kristin A. MD, Jonathan J. MD,